Polycystic Ovary Syndrome, which has just been renamed Polyendocrine Ovarian Syndrome (PMOS), is the most common hormonal and metabolic disorder affecting women of reproductive age, impacting up to 13% of this population ...
May 18, 2026
0
6
Research from Oregon Health & Science University sheds new light on the unintended consequences of the overturn of Roe v. Wade: worse medical care for miscarriages.
May 18, 2026
0
5
A select group of patients with early-stage breast cancer were able to omit surgery with no tumor progression after three years, according to results of a Phase 2 trial of ablative radiation therapy and endocrine therapy ...
May 18, 2026
0
4
A University of Mississippi study reveals that young women aged 16 to 24 across the nation do not necessarily have the needed knowledge when it comes to birth control.
May 18, 2026
0
3
The U.S. Supreme Court has preserved access to mifepristone—the medication used in the majority of abortions in the United States and in some miscarriage care—for now. The action maintains current rules that allow certified ...
May 18, 2026
0
4
For more than two decades, I have studied a condition that shapes the lives of about 10–13% of women. This condition causes complex, wide-ranging symptoms such as irregular periods, excessive hair growth, weight gain, acne ...
May 18, 2026
0
3
While sleep is essential to health, women face unique challenges to getting quality sleep across key life stages. According to new survey results from the American Academy of Sleep Medicine, more than a third of women ages ...
May 18, 2026
0
3
It's widely known that low-income Black women suffer far higher maternal health risks than low- income white mothers, often because they lack access to quality health care. But in a new book, UC Berkeley law professor Khiara ...
May 18, 2026
0
2
Several states have joined President Donald Trump's deportation efforts and are taking federal reporting requirements to immigration authorities a step further—by using their public health agencies as arms of enforcement.
May 18, 2026
0
3
New research published in JAMA Network Open suggests that there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.
May 17, 2026
0
22
